$770.3 M

ANGO Mkt cap, 18-Jul-2018

$86.7 M

AngioDynamics Revenue Q2, 2018
AngioDynamics Gross profit (Q2, 2018)42.7 M
AngioDynamics Gross profit margin (Q2, 2018), %49.3%
AngioDynamics Net income (Q2, 2018)249 K
AngioDynamics EBIT (Q2, 2018)1.1 M
AngioDynamics Cash, 30-Nov-201749.9 M
AngioDynamics EV814.4 M

AngioDynamics Revenue

AngioDynamics revenue was $353.89 m in FY, 2016 which is a 0.9% year over year decrease from the previous period.

Embed Graph

AngioDynamics Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016

Revenue

354.5 m357 m353.9 m

Revenue growth, %

1%(1%)

Cost of goods sold

174.6 m180.1 m179.6 m

Gross profit

179.9 m176.9 m174.3 m

Gross profit Margin, %

51%50%49%

Sales and marketing expense

84.7 m

R&D expense

25.1 m

General and administrative expense

29.6 m

Operating expense total

139.4 m

EBIT

13.4 m(994 k)1 m

EBIT margin, %

4%0%0%

Interest expense

3.7 m3.2 m3.4 m

Interest income

4 k11 k

Income tax expense

3.3 m(4.7 m)40.3 m

Net Income

3.1 m(3.3 m)(43.6 m)

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2018

Revenue

83.7 m89.2 m87.4 m86.7 m

Cost of goods sold

40.5 m43.4 m43.9 m44 m

Gross profit

43.2 m45.8 m43.5 m42.7 m

Gross profit Margin, %

52%51%50%49%

Sales and marketing expense

20.6 m20.6 m20.3 m19 m

R&D expense

6.2 m6.2 m5.8 m6.1 m

General and administrative expense

7.4 m8.1 m6.8 m7.5 m

Operating expense total

42.1 m44.5 m40.8 m41.6 m

Depreciation and amortization

4.1 m

EBIT

1.1 m1.3 m2.7 m1.1 m

EBIT margin, %

1%1%3%1%

Interest expense

800 k998 k809 k760 k

Interest income

1 k1 k2 k

Pre tax profit

83 k

Income tax expense

83 k(366 k)382 k(166 k)

Net Income

(426 k)(99 k)5.1 m470 k1.3 m(4.3 m)(757 k)(362 k)630 k249 k

AngioDynamics Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016

Cash

16.1 m18.4 m32.3 m

Inventories

61.1 m67.4 m55.4 m

Current Assets

152.2 m155.8 m146.3 m

PP&E

67.2 m54.6 m48.3 m

Goodwill

360.3 m361.3 m361.3 m

Total Assets

800.2 m773.6 m727.1 m

Accounts Payable

32.9 m23.7 m15.6 m

Short-term debt

5 m8.8 m16.3 m

Current Liabilities

72.3 m61.2 m66.7 m

Long-term debt

128.9 m105.2 m

Total Debt

137.7 m121.4 m

Total Liabilities

219.8 m

Additional Paid-in Capital

508.3 m520.1 m525.8 m

Retained Earnings

32.7 m28.2 m(16 m)

Total Equity

545 m507.2 m

Debt to Equity Ratio

0.3 x0.2 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.4 x1.4 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2018

Cash

22.1 m15.2 m7.4 m13.8 m14.9 m19.7 m20.3 m19 m21.9 m49.9 m

Inventories

59.2 m60.1 m59.8 m70.4 m75.3 m68.7 m74.3 m70.8 m65.8 m54 m

Current Assets

145.2 m141.6 m140.1 m154.3 m163.4 m157.3 m160 m151.6 m149.4 m152.5 m

PP&E

51.2 m49.7 m43.8 m

Goodwill

359.7 m359.7 m359.7 m360.5 m360.5 m360.5 m361.3 m361.3 m361.3 m361.3 m

Total Assets

801.2 m795.5 m792.2 m796.1 m799.3 m783.1 m771.8 m760.4 m753.5 m697.8 m

Accounts Payable

26.7 m28.3 m25.5 m29.3 m22 m21.7 m24.9 m21.7 m18.1 m21.8 m

Short-term debt

13.1 m5 m5 m5 m6.3 m7.5 m10 m11.3 m12.5 m5 m

Current Liabilities

74.4 m69.1 m63.4 m63.7 m57.9 m59.7 m60.7 m60.1 m61.6 m59.7 m

Long-term debt

129.4 m141.4 m126.4 m122.7 m113.9 m89 m

Total Debt

142.5 m5 m5 m5 m6.3 m148.9 m136.4 m133.9 m126.4 m94 m

Total Liabilities

272.7 m265.8 m254.5 m256.4 m255.8 m239.4 m224.7 m212.7 m202.8 m176.6 m

Additional Paid-in Capital

502.3 m504 m506.6 m510.7 m513.4 m518.3 m523 m524.2 m526.5 m538.4 m

Retained Earnings

29.1 m29 m34.1 m32 m33.3 m29 m27.5 m27.1 m27.7 m(11 m)

Total Equity

528.4 m529.7 m537.7 m547.1 m547.6 m550.7 m521.2 m

Financial Leverage

1.5 x1.5 x1.5 x1.4 x1.4 x1.4 x1.3 x

AngioDynamics Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016

Net Income

3.1 m(3.3 m)(43.6 m)

Depreciation and Amortization

16.8 m17.9 m18 m

Accounts Receivable

(15 m)2.1 m3.1 m

Inventories

(5.4 m)(6.2 m)12 m

Cash From Operating Activities

25.3 m26.2 m45.2 m

Purchases of PP&E

(11.8 m)(11.9 m)(2.3 m)

Cash From Investing Activities

(17 m)(13.3 m)(7.6 m)

Long-term Borrowings

(146.3 m)(20 m)(16.3 m)

Cash From Financing Activities

(14 m)(10.5 m)(23.7 m)

Interest Paid

3.6 m3.2 m3.1 m

Income Taxes Paid

182 k699 k332 k

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(426 k)(525 k)4.6 m470 k1.8 m(2.5 m)(757 k)(1.1 m)(489 k)

Depreciation and Amortization

6.1 m12.3 m18.8 m6.7 m14 m22.8 m7.2 m14.4 m21.4 m

Accounts Receivable

1.9 m(103 k)(9.7 m)5.8 m3.1 m3.5 m5.9 m4.9 m2.5 m

Inventories

(3.5 m)(4.4 m)(4.2 m)(9.2 m)(14.1 m)(7.5 m)(6.9 m)(3.5 m)1.5 m

Cash From Operating Activities

7.3 m15.8 m15.2 m5.4 m3.2 m15.4 m4.7 m14.3 m26.7 m

Purchases of PP&E

(2.9 m)(7.2 m)(9 m)(5.1 m)(7.5 m)(11 m)(743 k)(1.2 m)(1.9 m)

Cash From Investing Activities

(6.8 m)(11.2 m)(13 m)(5.3 m)(7.8 m)(12 m)(743 k)(1.1 m)(3.9 m)

Long-term Borrowings

(1.9 m)(143.8 m)(145 m)(1.3 m)(2.5 m)(8.8 m)(1.3 m)(3.8 m)(11.3 m)

Cash From Financing Activities

(272 k)(11.2 m)(16.7 m)(2.4 m)3.4 m641 k(2.1 m)(12.4 m)(19.2 m)

AngioDynamics Ratios

USDY, 2017

EV/EBIT

725.2 x

Revenue/Employee

69.4 k

Financial Leverage

1.3 x
Report incorrect company information